Rallybio Corp (RLYB) — Cash Flow-to-Debt Ratio
Rallybio Corp (RLYB) has a Cash Flow-to-Debt Ratio of -1.90x as of March 2026, meaning its operating cash flow of $-7.98 Million could theoretically repay -2% of its total liabilities ($4.20 Million) in one year. Explore Rallybio Corp long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Rallybio Corp Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Rallybio Corp across 7 annual periods. Also explore Rallybio Corp assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Rallybio Corp (2019–2025)
Year-by-year debt coverage analysis for Rallybio Corp. For market capitalisation and broader financial context, see Rallybio Corp stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.93x | $-29.81 Million | $4.30 Million | ▲ +9.3% |
| 2024 | -7.64x | $-49.28 Million | $6.45 Million | ▼ -19.6% |
| 2023 | -6.39x | $-60.27 Million | $9.44 Million | ▼ -24.0% |
| 2022 | -5.15x | $-57.28 Million | $11.12 Million | ▲ +25.5% |
| 2021 | -6.92x | $-45.53 Million | $6.58 Million | ▼ -83.8% |
| 2020 | -3.76x | $-22.04 Million | $5.86 Million | ▼ -18.9% |
| 2019 | -3.17x | $-15.03 Million | $4.75 Million | — |